Table 1. Baseline characteristics of study participants.
| STEMI n = 49 |
NSTEMI n = 24 |
p value | |
|---|---|---|---|
| Age in years | 62.2 ± 9.4 | 64.7 ± 9.9 | 0.24 |
| Age ≥ 70 | 11 (23) | 8 (33) | 0.47 |
| Female | 11 (23) | 9 (38) | 0.17 |
| BMI in kg/m2 | 27.4 ± 4.2 | 27.4 ± 3.6 | 0.8 |
| Hypertension | 21 (43) | 16 (67) | 0.056 |
| Diabetes mellitus | 7 (14) | 3 (13) | 0.87 |
| Dyslipidemia | 46 (94) | 21 (88) | 0.63 |
| Current smoker | 25 (51) | 8 (33) | 0.15 |
| Prior MI | 5 (10) | 2 (8) | 0.86 |
| Prior PCI | 4 (8) | 3 (13) | 0.86 |
| Prior CABG | 0 (0) | 0 (0) | n/a |
| Congestive heart failure | 0 (0) | 0 (0) | n/a |
| Nonhemorrhagic stroke | 1 (2) | 0 (0) | 0.71 |
| Peripheral arterial disease | 2 (4) | 2 (8) | 0.71 |
| Chronic renal disease | 0 (0) | 0 (0) | n/a |
| Chronic obstructive pulmonary disease | 0 (0) | 0 (0) | n/a |
| Gout | 1 (2) | 1 (4) | 0.8 |
| Heart rate at admission in bpm | 78 ± 16 | 75 ± 14 | 0.38 |
| SBP at admission in mmHg | 137 ± 36 | 145 ± 20 | 0.16 |
| DBP at admission in mmHg | 82 ± 15 | 83 ± 15 | 0.96 |
| Killip class I at admission | 42 (86) | 22 (92) | 0.71 |
| Creatinine at admission in mg/dL | 0.85 [0.77–0.98] | 0.80 [0.71–0.92] | 0.078 |
| GFR at admission in mL/minute | 81 [72–96] | 85 [78–90] | 0.57 |
| Morphine administration | 27 (55) | 10 (42) | 0.69 |
| GP IIb/IIIa inhibitors administration | 16 (33) | 3 (13) | 0.067 |
| Three-vessel coronary artery disease | 13 (27) | 7 (29) | 0.97 |
| LVEF at discharge in % | 45 [40–50] | 50 [45–51] | 0.027 |
Data are shown as mean ± standard deviation, median [interquartile range] or number (%). BMI: body mass index, bpm: beats per minute; CABG: coronary artery bypass grafting, DBP: diastolic blood pressure, GFR: glomerular filtration rate, GP: glycoprotein, LVEF: left ventricle ejection fraction, MI: myocardial infarction, n/a: not applicable, NSTEMI: non-ST-elevation myocardial infarction, PCI: percutaneous coronary intervention, SBP: systolic blood pressure, STEMI: ST-elevation myocardial infarction.